Advertisement

Topics

Ambry Launches Innovative Tumor/Germline Testing to Help Clinicians Guide Patient Treatment

06:00 EDT 6 Jun 2017 | Businesswire
This article has expired, however you can still download the PDF.
Preview:
By analyzing both germline and somatic mutations, Ambry can clearly identify those with hereditary cancer as well as those who may benefit from PARP inhibitor treatment or PD-L1/PD-1 immunotherapy Ambry Genetics (Ambry), a l...

Other Sources for this Article

Ambry Genetics
Aaron Schmidt
Corporate Communications Manager
949-457-4679
aschmidt@ambrygen.com

NEXT ARTICLE

More From BioPortfolio on "Ambry Launches Innovative Tumor/Germline Testing to Help Clinicians Guide Patient Treatment"

Quick Search
Advertisement
 

Relevant Topics

Cancer Disease
Cancer is not just one disease but many diseases. There are more than 100 different types of cancer. Most cancers are named for the organ or type of cell in which they start - for example, cancer that begins in the colon is called colon cancer; cancer th...

Biological Therapy
Biological therapy involves the use of living organisms, substances derived from living organisms, or laboratory-produced versions of such substances to treat disease. Some biological therapies for cancer use vaccines or bacteria to stimulate the body&rs...